Scale Advanced Therapy Supply Chains Globally Without Building Globally
Earn a Certificate of Live Attendance
AI Webinar Explorer available after event
About this webinar
When it comes to advanced therapies, expanding globally involves more than establishing additional sites or capabilities. Transitioning to multisite clinical trials or preparing for commercialization requires thoughtful planning, regional expertise and a supply chain infrastructure that can support growth without unnecessary operational complexity. This webinar will explore strategies for simplifying global expansion in advanced therapies.
The discussion will examine how life sciences organizations can navigate regional differences, establish a stronger presence in key markets and leverage existing infrastructure to support both clinical and commercial objectives.
The featured speakers will share insights on the evolving advanced therapy landscape across Asia-Pacific, highlighting emerging opportunities, market-specific considerations and key factors for organizations considering expansion into the region. The featured speakers will also discuss the critical role of specialized advanced therapy medicinal product (ATMP) expertise, local regulatory knowledge and cross-border logistics management in supporting advanced therapy supply chains across Europe. The discussion will also address country-specific regulatory, customs and tax requirements to enable successful clinical and commercial operations.
The featured speakers will also examine the role of Global Supply Chain Centers (GSCCs) in connecting advanced therapy operations across regions. From improving coordination and visibility to reducing operational burden, integrated supply chain networks can provide access to specialized capabilities while reducing the need for significant investments in additional infrastructure.
Attendees will gain insights into regional market dynamics, operational considerations and the role of integrated supply chain infrastructure in supporting international clinical development and commercialization.
Register for this webinar to learn how strategic supply chain planning can reduce operational complexity and support global expansion in advanced therapies.
Who should attend
- Supply Chain, Logistics or Operations
- Quality Assurance, Compliance or Regulatory Affairs
- MSAT, CMC, PD or R&D
- Clinical Trial Management
- Clinical to Commercial Scale-Up
- Consulting, Contract Research or Manufacturing
- Vendor Supply Chain Management
What you will learn
- The key considerations for expanding advanced therapy operations across APAC and Europe, including regional market dynamics and regulatory requirements
- Practical strategies for transitioning from regional clinical programs to global clinical and commercial operations
- How established global infrastructure with regional expertise can help organizations expand efficiently while minimizing the need for significant capital investment and operational build-out
- Approaches for leveraging interconnected supply chain capabilities to improve coordination and scalability across multiple markets
Featured Speakers
Nathan Dai
Nathan Dai is a Global Business Executive with roughly 30 years of experience in strategic partnerships and international business development. As the Vice President of Business Development in the Asia-Pacific region, Nathan helps drive market success for Cryoport Systems, a global leader in temperature-controlled supply chain solutions for advanced therapies.
Nathan earned his MSc in Industrial Engineering from Purdue University as well as an MBA from Harvard Business School. Prior to Cryoport Systems, he developed his career across several industries in both the US and Asia, including agriculture machinery, oil and gas equipment, renewable energy and an industrial chemical business. Nathan has developed a valuable skillset, including deep industry knowledge of business strategy, international logistics, crisis management and strategic alliances.
Florent Belon
Florent Belon is a Biological Engineer with expertise in logistics and supply chain techniques in the pharmaceutical industry. As a Co-Founder and CEO of Cell&Co Bioservices, which was acquired by Cryoport Systems in 2022, he led the strategic and commercial development of the company, building a BioServices business that supports clinical and commercial biopharmaceutical therapies in France and internationally.
He earned a Biological Engineering degree from Polytech Clermont and spent a year in the US conducting research in the chemical engineering laboratory of the University of Michigan. After his education, Florent joined Servier’s clinical supply coordination department, followed by Alliance Healthcare’s supplies department, where he developed logistics partnerships and expertise in pharmaceutical supply chain management, logistics partnerships and commercial negotiations.
Florent has an entrepreneurial mindset and a passion for innovative projects, operational excellence and long-term value creation. At Cryoport Systems, he leads global integration and strategic initiatives across the BioServices business, fostering synergy across teams in France, the US and other global locations to support the development and distribution of advanced therapies.
Mike Dybicz
Mike Dybicz is a skilled industry leader heading up Cryoport Systems’ consulting services group and new product development. He inspires innovative approaches and advances product solutions to scale value and meets the needs of the advanced therapies markets.
Mike has a BSc in Biomedical Engineering from Rensselaer Polytechnic Institute and an MBA from Carnegie Mellon University. He has established over 25 years of experience in product, process and strategy execution across a diverse range of industries. He previously helped develop groundbreaking advanced text analytics software as a service at IBM Research, provided innovative models of cares to healthcare service companies and managed boutique management advisory firms, among several other major career successes.
Recognized for balancing business and technical depth within his work and motivational leadership, Mike is helping build the future of Cryoport Systems’ extensive product line.
Partner for this event
Cryoport Systems
Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the Life Sciences industry. We are already trusted to support over 650 active clinical trials and leading commercial products worldwide, delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management. And, as the Life Sciences constantly evolve and advance, so do we.